Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NOTA Evans Blue PET/CT in Lymphatic Diseases
NCT05140083Phase 1Unknown
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Apr 2021
- Primary completion
- Dec 2024
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-NOTA-Evans Blue in lymphatic system disease, sponsored by The First Hospital of Fujian Medical University. Primary endpoints: Visual analysis of lymphatic patency at 3 years and Standardized uptake value at 3 years. Status: unknown.
02
Drugs
68Ga-NOTA-Evans Blue
03
Conditions
lymphatic system disease
Beyond the preview
Go deeper on NCT05140083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05140083.